Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 60 % of short-term debt in 2024; threshold 65 %.
Financials
Financial year 2024
BioConAct from Sint-Martens-Latem, company number BE0745917924, closed financial year 2024 with a result of € 21,495 after tax. For that financial year BioConAct recorded a gross margin of € 30,574 and equity of € 51,098. Compared with financial year 2023, the result moved from € 29,503 to € 21,495. The company is profitable. The buffer shrank hard: equity is 54 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 14, 2025.
€ 51,098
▼ 54% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 21,495
▼ 27% vs 2023
Profit after tax over the fiscal year.
€ 19,811
▼ 18% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 80,538 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2024
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 1,540
▼ 38% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 14,162
▲ 43% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 37,587
▲ 68% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 37,466 | € 41,336 | € 54,264 | € 30,574 | ▼ 44% |
| Profit after taxes | € 26,709 | € 32,050 | € 29,503 | € 21,495 | ▼ 27% |
| Equity | € 48,588 | € 80,638 | € 110,141 | € 51,098 | ▼ 54% |
| Total debts | € 21,317 | € 29,442 | € 32,307 | € 120,206 | ▲ 272% |
| Cash | € 27,068 | € 67,210 | € 24,277 | € 19,811 | ▼ 18% |
| Retained profit | € 48,488 | € 80,538 | € 110,041 | € 50,998 | ▼ 54% |
| Dividend | € 0 | € 0 | € 0 | € 80,538 | |
| Balance sheet total | € 69,905 | € 110,080 | € 142,448 | € 171,304 | ▲ 20% |
Key figures of BioConAct, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to BioConAct?
What happened at BioConAct in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 21,495 (▼ 27% vs 2023). filed late Source: NBB ↗
- New establishment in Sint-Martens-Latem. KBO
- Start of the company according to the CBE. KBO
In short
From € 26,709 profit in 2021 to € 21,495 profit in 2024.
Paid € 49,443 in corporate taxes since 2021.
Best year ever: 2022, with € 32,050 profit.
Paid out € 80,538 in dividends to the owners in total.
A new publication or filing at BioConAct? We notify you, reason included.
Follow BioConActDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind BioConAct is Katrien Vanhonacker. Katrien Vanhonacker is also behind MyCellHub and @DVisory Consultants.
Directors
According to the 2024 annual accounts
Establishments
Establishment units
Physical locations of this company
Kurs 6
9831 Sint-Martens-Latem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0745.917.924
- VAT number
- BE 0745.917.924
- Registered office
- Kurs 6, 9831 Sint-Martens-Latem
- Names & denominations
- BioConAct
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 April 2020
- Peppol
- Active · Active since 18 Nov 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Adviesbureaus op het gebied van public relations en communicatie
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige vormen van onderwijs
Overige technische testen en toetsen
Speur- en ontwikkelingswerk op het gebied van de maatschappij- en geesteswetenschappen
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
+1